期刊文献+

肾小球疾病患者临床和肾脏病理学因素对高尿酸血症患病率的影响 被引量:4

Relationship between the incidence of hyperuricemia and the clinical and pathological features in patientswith renal glomerular disease
原文传递
导出
摘要 目的探讨肾小球疾病患者临床和病理学因素对高尿酸血症(HUA)患病率的影响。方法回顾性分析2007年1月至2011年12月间,经肾脏活检确诊的3547例肾小球疾病患者的临床和病理学资料,并进行统计学分析。结果(1)在所有肾小球疾病患者中,HUA患病率为21.8%(773/3547),其中继发性肾小球疾病27.2%(240/882)高于原发性的20.7%(552/2665),差异有统计学意义(X^2=153.642,P〈0.05);原发性肾小球疾病中膜性肾病HUA的患病率最低,为14.4%(96/665);继发性肾小球疾病中狼疮性肾炎HUA的患病率最高,为45.3%(110/243),小血管炎肾损害[34.7%(17/49)]次之。(2)随着肾小球硬化指数、肾小管间质积分、肾内血管病变积分和慢性肾脏病分期的增加,HUA患病率进行性增加(X^2值为17.798-298.216,P均=0.000)。(3)二项Logistic回归分析提示:肾小管间质积分和肾小球硬化指数高、肾功能减退、男性、超重或肥胖、高血压和高甘油三酯均是HUA的危险因素(OR为1.011-7.513,P均〈0.05)。结论近1/4的。肾小球疾病患者血尿酸升高;肾小管间质病变重、肾小球硬化指数高、。肾小球滤过功能差、男性、超重或肥胖、高血压和高甘油三酯均是HUA的独立危险因素。 Objective To explore the effect of clinical and pathological features on the incidence of Hyperuricemia (HUA) in renal glomerular disease. Methods A retrospective analysis was applied to review the clinical and pathologieal date collected from 3547 patients with renal glomerular disease. These patients were diagnosed as renal glomerular disease by renal biopsy from January 2007 to December 2011. Results ( 1 ) HUA incidence was 21.8% (773/3547) in all of the patients,in which the incidence in secondary glomerular disease 27.2% (240/882) was much higher than that in primary glomerular disease 20.7% (552/2665), and the difference was significant ( X^2 = 153. 642, P 〈 0.05 ). In primary glomerular disease, HUA incidence was the lowest in membranous nephropathy 14.4% (96/665), while HUA incidence in lupus nephritis (LN) 45.3% ( 110/243 ) was the highest and small blood vessel infammation kidney damage 34. 7% (17/49) was the second in secondary glomerular disease. ( 2 ) With the increasing of glomeruloselerosis index, tubulointerstitial score, renal vascular lesions score and the stage of chronic kidney disease, HUA incidence increased ( X^2 = 17. 798 - 298. 216,P = 0. 000). (3)Logistic regression analysis showed that high tubulointerstitial score,glomerul- oselerosis index and renal dysfunction, male, overweight or obese, hypertension and hypertriglyceridemia were risk factors for hyperuricernia ( OR: 1. 011 - 7.513, P 〈 0. 05 ). Conclusion The uric acid level is increased in nearly a quarter of patients with renal glomerular disease. Severe tubulointerstitial lesion, high gjomerulosclerosis index, low glomerular filtration rate, male, overweight or obese, hypertension and hypertriglyceridemia were independent risk factors for HUA.
出处 《中国综合临床》 2013年第1期65-68,共4页 Clinical Medicine of China
关键词 肾小球疾病 慢性.肾脏病 高尿酸血症 患病率 Renal glomerular disease Chronic kidney disease Hyperuricemia Incidence
  • 相关文献

参考文献22

  • 1邹贵勉,黄江燕,车文体,眭维国,董力,陈洁晶,向月应,邹和群.广西城市社区居民高尿酸血症流行病学调查及其与慢性肾脏病的关系[J].中华内分泌代谢杂志,2011,27(7):561-565. 被引量:70
  • 2Bellomo G, Venanzi S, Verdura C, et al. Association of uric acid with change in kidney function in healthy normotensive individuals [J]. Am J Kidney Dis,2010,56(2) :264-272.
  • 3Zoppini G,Targher G, Chonehol M, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function [J]. Diabetes Care, 2012,35 ( 1 ) : 99-104.
  • 4Chen JH,Chuang SY,Chen HJ,et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study [J]. Arthritis Rheum,2009,61 (2) :225-232.
  • 5Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population [J]. Am J Med Sci,2010,339(6) :509- 515.
  • 6Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level [ J ]. Am J Kidney Dis,2006,47 ( 1 ) : 51-59.
  • 7Delanaye P, Cavalier E, Mariat C, et al. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant [ J ]. BMC Nephrol, 2010,11 : 8.
  • 8无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J].中国综合临床,2010,26(7):780-784. 被引量:25
  • 9Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease : a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)[J]. Kidney Int, 2005,67 ( 6 ) : 2089 -2100.
  • 10Hirayaraa F, Lee AH, Binns CW, et al. Persistent smoking by Japanese patients within four years from diagnosis of chronic obstructive pulmonary disease [J]. Addict Behav, 2008,33 ( 9 ) : 1235-1238.

二级参考文献65

共引文献112

同被引文献56

  • 1Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk [ J]. Curt Pharm Des,2013,19 (13) :2432-2438.
  • 2Qiu L, Cheng XQ, Wu J, et al. Prevalence of hyperurieemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces [ J]. B MC Public Health,2013,13 (1) :664.
  • 3Viazzi F, Leoncini G, Ratto E, et al. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived [J]. J Clin Hypertens (Greenwich),2006,8(7) :510-518.
  • 4de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences [J]. Diabetol Metab Syndr,2012,4:12.
  • 5Liu WC, Hung CC, Chen SC, et al. Association of hyperuricemia with renal outcomes,cardiovascular disease, and mortality [ J ]. Clin J Am Soc Nephrol,2012,7(4) :541-548.
  • 6So A, Thorens B. Uric acid transport and disease [J]. J Clin Invest ,2010,120 (6) : 1791-1799.
  • 7Sull JW, Park E J, Lee M,et al. Effects of SLC2A9 variants on uric acid levels in a Korean population [J]. Rheumatol Int, 2013,33 (1) :19-23.
  • 8Jang WC, Nam YH, Ahn YC, et al. G109T polynaorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome [ J]. Rheumatol Int, 2012,32 ( 8 ) : 2257- 2263.
  • 9Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout [ J ]. Proc Natl Acad Sci USA ,2009,106(25 ) :10338- 10342.
  • 10Latif W, Karaboyas A,Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population [J]. Clin J Am Soc Nephrol,2011,6 (10) :2470-2407.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部